Spinal Muscular Atrophy: Expanded Access as an Instrument of Fairness

被引：0
|
作者：
Beninger, Paul [1 ]
机构：
[1] Tufts Univ, Sch Med, Publ Hlth & Community Med, Boston, MA 02155 USA
来源：
CLINICAL THERAPEUTICS | 2024年 / 46卷 / 04期
关键词：
D O I：
10.1016/j.clinthera.2024.03.010
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：305 / 306
页数：2
相关论文
共 50 条
  • [1] Nusinersen for spinal muscular atrophy - results of an expanded access programme
    Mazurkiewicz-Beldzinska, Maria
    Kotulska-Jozwiak, Katarzyna
    Kopyta, Ilona
    Modrzejewska, Sandra
    Emich-Widera, Ewa
    Tomaszek, Katarzyna
    Paprocka, Justyna
    Chmielewski, Dariusz
    Pilch, Jacek
    Pietruszewski, Jerzy
    Lemska, Anna
    NEUROLOGY, 2019, 92 (15)
  • [2] An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy
    Kwon, Jennifer M.
    Arya, Kapil
    Kuntz, Nancy
    Phan, Han C.
    Sieburg, Cory
    Swoboda, Kathryn J.
    Veerapandiyan, Aravindhan
    Assman, Beverly
    Bader-Weder, Silvia
    Dickendesher, Travis L.
    Hansen, Jennifer
    Lin, Helen
    Yan, Ying
    Rao, Vamshi K.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2022, 9 (06): : 810 - 818
  • [3] Nusinersen treatment of spinal muscular atrophy type 1-results of expanded access programme in Poland
    Modrzejewska, Sandra
    Kotulska, Katarzyna
    Kopyta, Ilona
    Gredowska, Ewa
    Emich-Widera, Ewa
    Tomaszek, Katarzyna
    Paprocka, Justyna
    Chmielewski, Dariusz
    Pilch, Jacek
    Pietruszewski, Jerzy
    Lemska, Anna
    Zawadzka, Marta
    Mazurkiewicz-Beldzinska, Maria
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2021, 55 (03) : 289 - 294
  • [4] Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study
    Petra Kiefer
    Janbernd Kirschner
    Astrid Pechmann
    Thorsten Langer
    Orphanet Journal of Rare Diseases, 15
  • [5] Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study
    Kiefer, Petra
    Kirschner, Janbernd
    Pechmann, Astrid
    Langer, Thorsten
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [6] Lifesaving Treatments for Spinal Muscular Atrophy: Global Access and Availability
    Armengol, Victor D.
    Darras, Basil T.
    Abulaban, Ahmad A.
    Alshehri, Ali
    Barisic, Nina
    Ben-Omran, Tawfeg
    Bernert, Gunther
    Castiglioni, Claudia
    Chien, Yin-Hsiu
    Farrar, Michelle A.
    Kandawasvika, Gwendoline
    Khadilkar, Satish
    Mah, Jean K.
    Marini-Bettolo, Chiara
    Osredkar, Damjan
    Pfeffer, Gerald
    Piazzon, Flavia
    Castellano, Inmaculada Pitarch
    Quijano-Roy, Susana
    Saito, Kayoko
    Shin, Jin-Hong
    Vazquez-Costa, Juan F.
    Walter, Maggie C.
    Wanigasinghe, Jithangi
    Xiong, Hui
    Griggs, Robert C.
    Roy, Bhaskar
    ANNALS OF NEUROLOGY, 2023, 94 : S242 - S243
  • [7] Access to orphan drugs for the treatment of spinal muscular atrophy in Spain
    Garcia-Parra, Beliu
    Guiu, Josep M.
    Modamio, Pilar
    Martinez-Yelamos, Antonio
    Marino-Hernandez, Eduardo L.
    Povedano, Monica
    REVISTA DE NEUROLOGIA, 2022, 75 (09) : 261 - 267
  • [8] Evaluating the respiratory health of children with spinal muscular atrophy type 1 on nusinersen under the Expanded Access Program (EAP)
    Edel, L.
    Muntoni, F.
    Robinson, V.
    Grime, C.
    Abel, F.
    Manzur, A.
    Munot, P.
    Scoto, M.
    Chan, E.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S78 - S79
  • [9] Spinal muscular atrophy
    Chokri, M.
    Salma, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [10] Spinal Muscular Atrophy
    Nicolau, Stefan
    Waldrop, Megan A.
    Connolly, Anne M.
    Mendell, Jerry R.
    SEMINARS IN PEDIATRIC NEUROLOGY, 2021, 37
12345